Keeping you up to date on recent developments in orthopedics, including: Light stimulation makes bones heavier; NCCN: New research finds low bone health testing rates after prostate cancer treatment; A diet high in prunes prevents bone loss associated with spinal cord injuries.
Keeping you up to date on recent developments in oncology, including: Study finds fluorescence visualization not associated with reduced recurrence of oral cancer; Immunocytokines jump-start anti-glioblastoma immunity; Study backs protons in treatment of localized prostate cancer.
Australian researchers are the first to discover how inflammation is triggered in motor neuron disease (MND) and identified the molecules involved, which could be the first step toward development of treatments to slow the progression of MND and possibly other debilitating neurological diseases.
Two teams of researchers have developed miniature models of the human heart that beat and function like the full-size organ. The team from Michigan State University (MSU) and Washington University in St. Louis developed a human heart organoid (hHO) that recapitulates embryonic heart development, providing an unmatched view into congenital heart defects. The organoid created by the researchers at the Medical University of South Carolina (MUSC) and Clemson University mimics the tissue dysfunction that occurs following a heart attack.
Keeping you up to date on recent developments in cardiology, including: Complications in pregnancy tied to increased risk of heart disease, stroke later on; Creating an artificial vessel; Hearts in space!
Keeping you up to date on recent developments in neurology, including: Hydrogel developed to help repair damaged nerves; Evidence of Alzheimer’s, Parkinson’s & MND in brains of young people exposed to dirty air; Study identifies brain cells most affected by epilepsy and new targets for their treatment.
Investigators at the University of Heidelberg have identified a previously unknown mechanism for excitotoxicity and used their insight to identify “unconventional neuroprotectant” compounds that could prevent cell death and reduce brain damage in a mouse model of stroke.